Targeted identification of immunogenic peptides

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/53 (2006.01)

Patent

CA 2622036

This invention relates generally to identifying peptide sequences involved in antibody binding to any protein for synthesis of vaccine treatments. This novel method allows for a more manageable vaccine peptide discovery and specific generation of unique immunogenic peptides from self-tumor associated proteins and/or foreign proteins from infectious organisms for specific and/or enhanced expression only in the presence of the antibody.

Cette invention porte, de manière générale, sur l'identification de séquences peptidiques intervenant dans la liaison d'anticorps à toute protéine dans la synthèse des thérapies vaccinales. Cette nouvelle méthode permet de rechercher des peptides vaccinaux plus gérables et une génération spécifique de peptides immunogènes uniques provenant d'autoprotéines associées à des tumeurs et/ou de protéines exogènes provenant d'organismes infectieux pour obtenir une expression spécifique et/ou améliorée uniquement en présence de l'anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Targeted identification of immunogenic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeted identification of immunogenic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted identification of immunogenic peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1695659

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.